STAAR Surgical (STAA) Receives CE Mark Approval for KS-X Preloaded Injector System
More News related to STAA
- STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
- STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
- STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
- STAAR Surgical Collamer(R) Accommodating Study Team Reports First Phase Assessments at AAO
- STAAR Surgical (STAA) Reports Progress on Japanese Application for Approval of Visian Implantable Collamer Lens
More News related to Corporate News
- Odyssey Marine (OMEX) Acquires Minority Stake in SMM Project LLC
- NASDAQ Grants Comstock Homebuilding (CHCI) Continued Listing Request
- Agilysys (AGYS) Announces Special Meeting of Shareholders to Vote on Proposed Control Share Acquisition by MAK Capital
- Highlights From SJM's Q2 Conference Call: Acquisition of Folger's Really Paying Off; Comfortable Raising FY Outlook
- Pfizer (PFE) Gets Okay for Bipolar Treatment Geodon from U.S. FDA
STAAR Surgical Company (Nasdaq: STAA) today announced that it has received CE Mark approval for its KS-X Preloaded Hydrophobic Acrylic Injector for use in minimally invasive cataract surgical procedures. The CE Mark allows STAAR Surgical to market this foldable intraocular KS-X lens delivery system in the European Union as well as other countries that recognize the CE Mark. It also signifies that STAAR's preloaded acrylic lens delivery system complies with applicable safety and quality standards.
STAAR has been offering the KS-X system, which mates a preloaded delivery system manufactured by STAAR Japan with an independently sourced acrylic lens, in the Japanese market for two years. The STAAR system enables lens delivery into the eye through a 2.8 millimeter incision and is compatible with the most commonly used small incision cataract extraction procedures. It is the only preloaded lens delivery system in the world that provides single or bi-manual injection options in one single design, allowing for the smoothest IOL injection methods compared with traditional delivery systems.
More from the release.
Related Categories
Corporate NewsStocks Mentioned
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
